Killed poliovirus antigen titration in humans

Area of Science:

• Vaccinology
• Immunology
• Pediatric Infectious Diseases

Background:

• Establishing optimal antigen content for vaccines is critical for efficacy and efficient immunization schedules.
• Killed poliovirus vaccine (IPV) requires precise antigen quantification to ensure robust immune responses.

Purpose of the Study:

• To determine the minimum antigen concentration of killed poliovirus vaccine (IPV) needed for seroconversion in infants after a single dose.
• To establish a reference standard vaccine with proven field efficacy.

Main Methods:

• Infant titration study to assess antibody response against varying concentrations of Types I, II, and III poliovirus antigens.
• Analysis of the relationship between antigen dose and antibody response, focusing on seroconversion rates.

Main Results:

• A linear relationship exists between antigen concentration and antibody response within a critical range.
• Over 90% seroconversion was achieved with 80, 8, and 64 D-antigen units for poliovirus Types I, II, and III, respectively.
• A four-fold reduction in antigen units for each type resulted in reduced vaccine effectiveness.

Conclusions:

• Specific D-antigen unit levels are identified as critical for a potent killed poliovirus vaccine.
• These findings support the development of an efficient immunization strategy using precisely quantified IPV.
• Optimized antigen content ensures vaccine potency and effective immunity with fewer doses.